ONCOLOGY

Breast Cancer Disparities

Sep 27, 2017 by in ONCOLOGY Comments Off on Breast Cancer Disparities

African American women have a lower lifetime incidence of breast cancer than white/Caucasian Americans yet have a higher risk of breast cancer mortality. African American women are also more likely…

read more

Nipple-Sparing Mastectomy

Sep 27, 2017 by in ONCOLOGY Comments Off on Nipple-Sparing Mastectomy

The guiding principles of nipple-sparing mastectomy (complete removal of the breast from its skin and reconstructing without changing the appearance of the breast) are based on patient safety followed by…

read more

Basal-Like and Triple-Negative Breast Cancers

Sep 27, 2017 by in ONCOLOGY Comments Off on Basal-Like and Triple-Negative Breast Cancers

Triple-negative breast cancers (TNBC) are defined by their failure to express the estrogen receptor, progesterone receptor, and HER2/ neu protein markers. This basic feature is clinically relevant because it indicates…

read more

Neoadjuvant Therapy in the Treatment of Breast Cancer

Sep 27, 2017 by in ONCOLOGY Comments Off on Neoadjuvant Therapy in the Treatment of Breast Cancer

Neoadjuvant systemic therapy in breast cancer treatment was initially utilized for inoperable disease. However, several randomized prospective studies have demonstrated comparable survival with adjuvant chemotherapy in early-stage, operable breast cancer…

read more

Lobular Neoplasia

Sep 27, 2017 by in ONCOLOGY Comments Off on Lobular Neoplasia

Lobular neoplasia (LN) is characterized by a dysfunctional E-cadherin-catenin axis, and loss of E-cadherin plays a causative role in the typical morphology of LN cells. LN is both a nonobligate…

read more

Management of Axillary Disease

Sep 27, 2017 by in ONCOLOGY Comments Off on Management of Axillary Disease

The presence of nodal metastases is the most important prognostic indicator in breast cancer, making accurate assessment of the axillary nodal basin critical to delivering optimal therapy in breast cancer….

read more

Molecular Profiling of Breast Cancer

Sep 27, 2017 by in ONCOLOGY Comments Off on Molecular Profiling of Breast Cancer

Breast cancer is now considered a heterogeneous and phenotypically diverse disease. Molecular profiling is used in clinical practice in 2 broad categories: (1) characterization of breast cancers beyond the standard…

read more
Get Clinical Tree app for offline access